GLYTHERIX
Company Overview
Social Media Profiles
About GlyTherix
Description
GlyTherix is an innovative immuno-oncology firm focused on developing cutting-edge cancer therapeutics. With a robust intellectual property portfolio, the company is dedicated to enhancing treatment options for solid tumors, aiming to significantly improve patient outcomes in the Biotechnology and Life Sciences industry.
Specialties
Immuno-oncology therapeutics
Targeting Glypican-1 (GPC-1)
First-in-Human clinical trials
Theranostic studies
Humanized monoclonal antibodies
Products & Services
Monoclonal Antibodies
Cancer Therapeutics
Immuno-Oncology Treatments
Theranostic Studies
Intellectual Property Solutions
Contact Information
No contact information available
Competitors & Similar Companies(6)
ImmunoGen
Mirati Therapeutics
Agenus
Zymeworks
Iovance Biotherapeutics
Adaptimmune
News & Media
Search Terms:
glytherix
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about GlyTherix
Where is GlyTherix located?
The headquarter of GlyTherix is located in Macquarie Park, New South Wales, Australia
What is the official website of GlyTherix?
The official website of GlyTherix is https://www.glytherix.com
What industry does GlyTherix belong to?
GlyTherix belongs to the Biotechnology, Biotechnology and Life Sciences industry.
What are the specialties of GlyTherix?
GlyTherix specializes in Immuno-oncology therapeutics, Targeting Glypican-1 (GPC-1), First-in-Human clinical trials, Theranostic studies, Humanized monoclonal antibodies.
What products and services is GlyTherix likely to offer?
GlyTherix offers Monoclonal Antibodies, Cancer Therapeutics, Immuno-Oncology Treatments, Theranostic Studies, Intellectual Property Solutions.
Who are the competitors of GlyTherix?
Competitors of GlyTherix are ImmunoGen, Mirati Therapeutics, Agenus, Zymeworks, Iovance Biotherapeutics, Adaptimmune.
What does GlyTherix do?
GlyTherix is an innovative immuno-oncology firm focused on developing cutting-edge cancer therapeutics. With a robust intellectual property portfolio, the company is dedicated to enhancing treatment options for solid tumors, aiming to significantly improve patient outcomes in the Biotechnology and Life Sciences industry.
What are the social media links of GlyTherix?
Social media links of GlyTherix areLinkedIn